 Connection
Mario Enrico Canonico to Cross-Over Studies
This is a "connection" page, showing publications Mario Enrico Canonico has written about Cross-Over Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.094 |
|
|
|
-
Piccolo R, Laino A, Vitale AP, Canonico ME, Avvedimento M, Simonetti F, Paolillo R, Piaz FD, Charlier B, Spinelli A, Cristiano S, Serafino LD, Cirillo P, Gargiulo G, Franzone A, Filippelli A, Conti V, Esposito G. Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg. J Thromb Thrombolysis. 2026 Mar; 59(3):551-563.
Score: 0.048
-
Piccolo R, Simonetti F, Avvedimento M, Cutillo M, Canonico ME, Conti V, Gargiulo G, Paolillo R, Dal Piaz F, Filippelli A, Charlier B, Spinelli A, Cristiano S, Cirillo P, Di Serafino L, Franzone A, Esposito G. Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial. Eur Heart J Cardiovasc Pharmacother. 2024 11 06; 10(7):578-587.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|